
Park Ha Biological Technology Co., Ltd. Ordinary Shares
Park Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) SEC Filings & 10-K Annual Reports
SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.
SEC EDGAR · data.sec.gov · CIK 0001986247 · BYAH · NASDAQ · as of Jun 8, 2026
Filing snapshot
Source: SEC EDGAR (data.sec.gov) · CIK 0001986247 · Updated hourly · Not investment advice
Latest Annual Report
Latest Key Filings
No recent filings
Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.
SEC Filing History
About SEC Filings & 10-K Annual Reports
Park Ha Biological Technology Co., Ltd. Ordinary Shares (NASDAQ: BYAH) has submitted 65 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2025. As a Consumer Cyclical sector company with CIK 0001986247, all filings are publicly accessible via the EDGAR database at no cost.
The annual 10-K report is Park Ha Biological Technology Co., Ltd. Ordinary Shares's most comprehensive regulatory disclosure. The most recent Park Ha Biological Technology Co., Ltd. Ordinary Shares 10-K was filed on 2026-03-02 for fiscal year ending 2026. Historical BYAH 10-K annual reports are available from 2023 through 2026.
Investors researching Park Ha Biological Technology Co., Ltd. Ordinary Shares SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.
Frequently Asked Questions
BYAH SEC Filings · 8 questionsPark Ha Biological Technology Co., Ltd. Ordinary Shares (BYAH) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 65 filings and access original documents at no cost. Park Ha Biological Technology Co., Ltd. Ordinary Shares's CIK is 0001986247.